Cytokinetics Inc (Cytokinetics) focuses on discovering, developing and commercializing muscle activators and inhibitors for muscle function disorders in cardiovascular and neuromuscular diseases. Its focus on research and development activities, increase in working capital and strategic collaborations are its major strengths, while a history of operating losses could be a cause for concern. Cytokinetics could benefit from strategic agreements, orphan drug designation, and increasing healthcare expenditure in the US. However, its performance could be negatively affected by the regulatory environment, stiff competition, and dependence on third-party contract manufacturers.
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer